Tamoxifen reduces the rate of breast cancer recurrence by approximately a half. Tamoxifen is metabolized to more active metabolites by enzymes encoded by polymorphic genes, including cytochrome P450 ...
Her2-targeted pegylated stealth liposomal doxorubicin (PLD) retains its specific targeting ability to Her2-expressing tumor cells after in vivo circulation and extravasation to mouse malignant ascites ...
Integrated analysis of pivotal biomarker, immune cell infiltration, and therapeutic drugs for LSM1-mutated in breast cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...
A new editorial paper titled "Targeting ABC transporters in PDAC—past, present, or future?" has been published in Oncotarget. Science X Daily and the Weekly Email Newsletter are free features that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback